4//SEC Filing
Kieffer Tara Lynn 4
Accession 0001062993-24-012734
CIK 0001177648other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:38 PM ET
Size
5.2 KB
Accession
0001062993-24-012734
Insider Transaction Report
Form 4
Kieffer Tara Lynn
Chief Product Strategy Officer
Transactions
- Sale
Common Stock
2024-06-17$12.33/sh−7,266$89,590→ 32,341 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2024.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.54, inclusive.
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001834835
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 8:38 PM ET
- Size
- 5.2 KB